Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 2
1993 1
1994 3
1995 1
1997 2
1998 3
1999 1
2002 3
2003 3
2004 3
2005 2
2007 4
2008 8
2009 7
2010 4
2011 6
2012 2
2014 3
2015 6
2016 3
2017 5
2018 3
2019 5
2020 3
2021 2
2022 3
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

84 results
Results by year
Filters applied: . Clear all
Page 1
European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency.
Miravitlles M, Dirksen A, Ferrarotti I, Koblizek V, Lange P, Mahadeva R, McElvaney NG, Parr D, Piitulainen E, Roche N, Stolk J, Thabut G, Turner A, Vogelmeier C, Stockley RA. Miravitlles M, et al. Among authors: piitulainen e. Eur Respir J. 2017 Nov 30;50(5):1700610. doi: 10.1183/13993003.00610-2017. Print 2017 Nov. Eur Respir J. 2017. PMID: 29191952 Free article. Review.
Eureka?
Stoel BC, Dirksen A, Stockley RA, Parr D, Piitulainen E, Shaker SB, Russi EW, Bakker ME, Reiber JH, Stolk J. Stoel BC, et al. Among authors: piitulainen e. Radiology. 2011 May;259(2):610-1; author reply 611-2. doi: 10.1148/radiol.11102262. Radiology. 2011. PMID: 21502395 No abstract available.
Cancer risk in severe alpha-1-antitrypsin deficiency.
Hiller AM, Ekström M, Piitulainen E, Lindberg A, Rönmark E, Tanash H. Hiller AM, et al. Among authors: piitulainen e. Eur Respir J. 2022 Oct 27;60(4):2103200. doi: 10.1183/13993003.03200-2021. Print 2022 Oct. Eur Respir J. 2022. PMID: 35361631
Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
Chapman KR, Burdon JG, Piitulainen E, Sandhaus RA, Seersholm N, Stocks JM, Stoel BC, Huang L, Yao Z, Edelman JM, McElvaney NG; RAPID Trial Study Group. Chapman KR, et al. Among authors: piitulainen e. Lancet. 2015 Jul 25;386(9991):360-8. doi: 10.1016/S0140-6736(15)60860-1. Epub 2015 May 27. Lancet. 2015. PMID: 26026936 Clinical Trial.
Survival in severe alpha-1-antitrypsin deficiency (PiZZ).
Tanash HA, Nilsson PM, Nilsson JA, Piitulainen E. Tanash HA, et al. Among authors: piitulainen e. Respir Res. 2010 Apr 26;11(1):44. doi: 10.1186/1465-9921-11-44. Respir Res. 2010. PMID: 20420704 Free PMC article.
84 results